Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Massachusetts General Hospital
mi
from
Boston, MA
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Henry Ford Health System
mi
from
Novi, MI
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Henry Ford Health System
mi
from
Novi, MI
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
The Mayo Clinic
mi
from
Rochester, MN
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Dartmouth College
mi
from
Lebanon, NH
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Dartmouth College
mi
from
Lebanon, NH
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Mt. Sinai School of Medicine
mi
from
New York, NY
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Mt. Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Asheville Gastroenterology Associates, P.A.
mi
from
Asheville, NC
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Asheville Gastroenterology Associates, P.A.
mi
from
Asheville, NC
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Charlotte Gastroenterology and Hepatology
mi
from
Charlotte, NC
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Charlotte Gastroenterology and Hepatology
mi
from
Charlotte, NC
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Great Lakes Gastroenterology
mi
from
Mentor, OH
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Great Lakes Gastroenterology
mi
from
Mentor, OH
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Penn State University
mi
from
State College, PA
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Penn State University
mi
from
State College, PA
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Medical University of South Carolina
mi
from
Charleston, SC
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Baylor University
mi
from
Houston, TX
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Baylor University
mi
from
Houston, TX
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
University of Utah
mi
from
Salt Lake City, UT
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Harborview Medical Center
mi
from
Seattle, WA
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Univ of Washington
mi
from
Seattle, WA
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
University of Wisconsin
mi
from
Madison, WI
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated:  4/24/2017
Shafran Gastroenterology
mi
from
Winter Park, FL
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Status: Enrolling
Updated: 4/24/2017
Shafran Gastroenterology
mi
from
Winter Park, FL
Click here to add this to my saved trials
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Status: Enrolling
Updated:  4/25/2017
Boston Med Ctr
mi
from
Boston, MA
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Status: Enrolling
Updated: 4/25/2017
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Birmingham, AL
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Mobile, AL
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Fayetteville, AR
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Anaheim, CA
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Orange, CA
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
San Diego, CA
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Wheat Ridge, CO
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Bridgeport, CT
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Hamden, CT
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Hamden, CT
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Gainesville, FL
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Hollywood, FL
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Naples, FL
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Naples, FL
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
South Miami, FL
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
South Miami, FL
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Winter Park, FL
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Atlanta, GA
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Macon, GA
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Macon, GA
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Moline, IL
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Moline, IL
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Topeka, KA
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Annapolis, MD
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Annapolis, MD
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Chevy Chase, MD
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Lutherville, MD
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Lutherville, MD
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Silver Spring, MD
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Troy, MI
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Troy, MI
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Kansas City, MO
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Mexico, MO
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Mexico, MO
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Lincoln, NE
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Cedar Knolls, NJ
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Cedar Knolls, NJ
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Great Neck, NY
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
New York, NY
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials